- Home
- ALEC vs PAYS Comparison
ALEC vs PAYS Comparison
Compare ALEC & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- PAYS
- Stock Information
- Founded
- ALEC 2013
- PAYS 2001
- Country
- ALEC United States
- PAYS United States
- Employees
- ALEC N/A
- PAYS N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- PAYS Business Services
- Sector
- ALEC Health Care
- PAYS Consumer Discretionary
- Exchange
- ALEC Nasdaq
- PAYS Nasdaq
- Market Cap
- ALEC 124.0M
- PAYS 125.2M
- IPO Year
- ALEC 2019
- PAYS 1998
- Fundamental
- Price
- ALEC $1.60
- PAYS $7.53
- Analyst Decision
- ALEC Buy
- PAYS Strong Buy
- Analyst Count
- ALEC 8
- PAYS 4
- Target Price
- ALEC $4.50
- PAYS $7.06
- AVG Volume (30 Days)
- ALEC 415.3K
- PAYS 950.3K
- Earning Date
- ALEC 08-11-2025
- PAYS 08-05-2025
- Dividend Yield
- ALEC N/A
- PAYS N/A
- EPS Growth
- ALEC N/A
- PAYS N/A
- EPS
- ALEC N/A
- PAYS 0.11
- Revenue
- ALEC $88,339,000.00
- PAYS $63,792,627.00
- Revenue This Year
- ALEC N/A
- PAYS $31.28
- Revenue Next Year
- ALEC $319.82
- PAYS $19.36
- P/E Ratio
- ALEC N/A
- PAYS $68.46
- Revenue Growth
- ALEC N/A
- PAYS 26.77
- 52 Week Low
- ALEC $0.87
- PAYS $1.80
- 52 Week High
- ALEC $6.52
- PAYS $8.88
- Technical
- Relative Strength Index (RSI)
- ALEC 49.80
- PAYS 53.21
- Support Level
- ALEC $1.74
- PAYS $7.55
- Resistance Level
- ALEC $2.00
- PAYS $8.88
- Average True Range (ATR)
- ALEC 0.12
- PAYS 0.47
- MACD
- ALEC -0.01
- PAYS -0.17
- Stochastic Oscillator
- ALEC 14.93
- PAYS 4.93
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.